Published in Patient Prefer Adherence on June 24, 2010
Insulin use and persistence in patients with type 2 diabetes adding mealtime insulin to a basal regimen: a retrospective database analysis. BMC Endocr Disord (2011) 0.86
Association Between Loyalty to Community Pharmacy and Medication Persistence and Compliance, and the Use of Guidelines-Recommended Drugs in Type 2 Diabetes: A Cohort Study. Medicine (Baltimore) (2015) 0.82
Adherence to insulin treatment in insulin-naïve type 2 diabetic patients initiated on different insulin regimens. Patient Prefer Adherence (2015) 0.79
Insulin adherence and persistence among Chinese patients with type 2 diabetes: a retrospective database analysis. Patient Prefer Adherence (2017) 0.75
Utilization patterns of insulin therapy and healthcare services among Japanese insulin initiators during their first year: a descriptive analysis of administrative hospital data. BMC Health Serv Res (2016) 0.75
I Have Never Liked the Term "Compliance". Clin Diabetes (2017) 0.75
Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study. Patient Prefer Adherence (2016) 0.75
Adherence to Insulin Pen Therapy Is Associated with Reduction in Healthcare Costs Among Patients with Type 2 Diabetes Mellitus. Am Health Drug Benefits (2015) 0.75
Association between interpersonal continuity of care and medication adherence in type 2 diabetes: an observational cohort study. CMAJ Open (2017) 0.75
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol (1992) 60.45
Standards of medical care in diabetes--2008. Diabetes Care (2008) 17.23
Economic costs of diabetes in the U.S. In 2007. Diabetes Care (2008) 15.73
A systematic review of adherence with medications for diabetes. Diabetes Care (2004) 7.67
Estimating medication persistency using administrative claims data. Am J Manag Care (2005) 3.95
A checklist for medication compliance and persistence studies using retrospective databases. Value Health (2007) 3.64
Impact of dosage frequency on patient compliance. Diabetes Care (1997) 2.43
Medication taking and diabetes: a systematic review of the literature. Diabetes Educ (2007) 1.85
Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Clin Ther (2005) 1.84
Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis. Clin Ther (2007) 1.58
Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a medicaid patient population with type 2 diabetes mellitus. Clin Ther (2001) 1.30
Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes. South Med J (2002) 1.24
Patient characteristics, drug adherence patterns, and hypoglycemia costs for patients with type 2 diabetes mellitus newly initiated on exenatide or insulin glargine. Curr Med Res Opin (2009) 1.17
Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization. Curr Med Res Opin (2010) 1.12
Predictors of persistence of use of the novel antidiabetic agent acarbose. Arch Intern Med (2001) 1.05
Barriers to the initiation of, and persistence with, insulin therapy. Curr Med Res Opin (2007) 0.96
Sleep problems, comorbid mental disorders, and role functioning in the national comorbidity survey replication. Biol Psychiatry (2006) 2.44
Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes (2008) 2.42
Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices. Pharmacoeconomics (2010) 1.70
Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes (2010) 1.60
Topiramate use in pregnancy and the birth prevalence of oral clefts. Pharmacoepidemiol Drug Saf (2014) 1.52
Improved pancreatic beta-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide. Diabetes Care (2010) 1.46
Patient-reported outcomes in insomnia: development of a conceptual framework and endpoint model. Behav Sleep Med (2013) 1.43
Over-the-counter medication labels: are we ignoring the needs of blind consumers? Optometry (2004) 1.38
A low-glycemic index diet combined with exercise reduces insulin resistance, postprandial hyperinsulinemia, and glucose-dependent insulinotropic polypeptide responses in obese, prediabetic humans. Am J Clin Nutr (2010) 1.32
The association between insomnia severity and healthcare and productivity costs in a health plan sample. Sleep (2011) 1.16
Association of insomnia severity and comorbid medical and psychiatric disorders in a health plan-based sample: Insomnia severity and comorbidities. Sleep Med (2009) 1.10
Randomized trial on the effects of a 7-d low-glycemic diet and exercise intervention on insulin resistance in older obese humans. Am J Clin Nutr (2009) 1.10
Nonrestorative sleep. Sleep Med Rev (2008) 1.04
Retrospective analysis of long-term adherence to and persistence with DPP-4 inhibitors in US adults with type 2 diabetes mellitus. Adv Ther (2014) 1.01
Nonresponse, partial response, and failure to achieve remission: humanistic and cost burden in major depressive disorder. Depress Anxiety (2009) 1.01
The implications of acute rejection and reduced allograft function on health care expenditures in contemporary US kidney transplantation. Transplantation (2012) 1.00
Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery. Obes Surg (2010) 0.99
Economic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States: results from a retrospective claims database analysis. J Med Econ (2012) 0.94
Tinea capitis among children in the Columbus area, Ohio, USA. Mycoses (2009) 0.93
Epidemiology, health-related quality of life and economic burden of binge eating disorder: a systematic literature review. Eat Weight Disord (2015) 0.92
Prevalence of pigmentary disorders and their impact on quality of life: a prospective cohort study. J Cosmet Dermatol (2008) 0.90
The clinical history and costs associated with delayed diagnosis of bipolar disorder. MedGenMed (2006) 0.90
Subtypes of sleep disturbance: associations among symptoms, comorbidities, treatment, and medical costs. Behav Sleep Med (2010) 0.90
Potential health care cost savings associated with early treatment of multiple sclerosis using disease-modifying therapy. Clin Ther (2011) 0.90
Improved hepatic lipid composition following short-term exercise in nonalcoholic fatty liver disease. J Clin Endocrinol Metab (2013) 0.89
Exercise training with weight loss and either a high- or low-glycemic index diet reduces metabolic syndrome severity in older adults. Ann Nutr Metab (2012) 0.88
Insulin use and persistence in patients with type 2 diabetes adding mealtime insulin to a basal regimen: a retrospective database analysis. BMC Endocr Disord (2011) 0.86
Medication utilization patterns among type 2 diabetes patients initiating Exenatide BID or insulin glargine: a retrospective database study. BMC Endocr Disord (2013) 0.85
Does cost-effectiveness play a role in clinical trials? Dermatol Ther (2007) 0.85
Long-acting insulin analogs: a review of "real-world" effectiveness in patients with type 2 diabetes. Curr Diabetes Rev (2011) 0.83
Use of 12-month renal function and baseline clinical factors to predict long-term graft survival: application to BENEFIT and BENEFIT-EXT trials. Transplantation (2012) 0.82
Intent-to-treat analysis of health care expenditures of patients treated with atypical antipsychotics as adjunctive therapy in depression. Clin Ther (2011) 0.81
Reduced cardiovascular risk following bariatric surgeries is related to a partial recovery from "adiposopathy". Obes Surg (2011) 0.81
Beneficial effect of belatacept on health-related quality of life and perceived side effects: results from the BENEFIT and BENEFIT-EXT trials. Transplantation (2014) 0.80
Effect of load carriage on lumbar spine kinematics. Spine (Phila Pa 1976) (2013) 0.79
A network meta-analysis of the efficacy of belatacept, cyclosporine and tacrolimus for immunosuppression therapy in adult renal transplant recipients. Curr Med Res Opin (2014) 0.79
The prevalence of complications and healthcare costs during pregnancy. J Med Econ (2015) 0.79
Treatment patterns, health care resource utilization, and costs in U.S. patients diagnosed with chronic hepatitis C infection who received telaprevir or boceprevir. J Manag Care Spec Pharm (2015) 0.77
The cost-effectiveness of daclatasvir-based regimens for the treatment of hepatitis C virus genotypes 1 and 4 in the UK. Eur J Gastroenterol Hepatol (2016) 0.77
Topiramate use during pregnancy and major congenital malformations in multiple populations. Birth Defects Res A Clin Mol Teratol (2015) 0.77
Psychometric properties of PedsQL generic core scales for children with functional constipation in the Netherlands. J Pediatr Gastroenterol Nutr (2014) 0.77
Productivity losses among treated depressed patients relative to healthy controls. J Occup Environ Med (2010) 0.76
Estimating the incremental net health benefit of requirements for cardiovascular risk evaluation for diabetes therapies. Pharmacoepidemiol Drug Saf (2014) 0.76
Costs of Newborn Care Following Complications During Pregnancy and Delivery. Matern Child Health J (2015) 0.75
Retracted Performance differences between male and female marines on standardized physical fitness tests and combat proxy tasks: identifying the gap. US Army Med Dep J (2015) 0.75
Effect of Load Magnitude and Distribution on Lumbar Spine Posture in Active-duty Marines. Spine (Phila Pa 1976) (2017) 0.75
Monitoring for medication errors in outpatient settings. J Dermatolog Treat (2009) 0.75
Evaluating the impact of unmeasured confounding with internal validation data: an example cost evaluation in type 2 diabetes. Value Health (2013) 0.75
A clinician's guide to the cost and health benefits of hepatitis C cure assessed from the individual patient perspective. Eur J Gastroenterol Hepatol (2016) 0.75
A meta-analysis platform methodology for determining the comparative effectiveness of antihepatitis C virus regimens. J Comp Eff Res (2015) 0.75